Aletha Maybank, MD, MPH recently joined the AMA in April 2019 as their inaugural Chief Health Equity Officer and Vice President. Her role is to embed health equity in all the work of the AMA and to launch a Center for Health Equity.
Prior to this in 2014, Dr. Maybank became an Associate Commissioner, and later a Deputy Commissioner, and lunched the Center for Health Equity, a new division in the NYC Department of Health and Mental Hygiene geared toward strengthening and amplifying the Health Department’s work in ending health inequities. Under her leadership, and in a short amount of time, the health department made great strides in transforming the culture and public health practice by embedding health equity in the health department’s work. This work has been recognized and adapted by other City agencies and has captured the attention of the CDC and WHO.
She also teaches medical and public health students on topics related to health inequities, public health leadership and management, physician advocacy, and community organizing health. Currently, Dr. Maybank serves as President of the Empire State Medical Association, the NYS affiliate of the National Medical Association. In 2012, she co-founded “We Are Doc McStuffins,” a movement created by African-American female physicians who are inspired by the Disney Junior character, Doc McStuffins.
Dr. Maybank holds a BA from Johns Hopkins University, an MD from Temple University School of Medicine, and an MPH from Columbia University Mailman School of Public Health. She is a pediatrician and board certified in Preventive Medicine and Public Health.
Lunch Plenary:
A Commitment to Advance Health Equity
California Enacts Law to Produce Generic Prescription Drugs
/in Prescription Drug Pricing California Blogs, Featured News Home Administrative Actions, Prescription Drug Pricing, State Rx Legislative Action /by Johanna ButlerLast week, California Gov. Gavin Newsom signed SB 852, a law enabling California to become the first state to produce its own generic prescription drugs, an idea first proposed in the Governor’s 2020-2021 budget. The new law aims to reduce the cost of generic drugs by boosting competition and increase patient access to certain generics, […]
Supreme Court Hears Arkansas Pharmacy Benefit Manager Challenge Today
/in Policy Arkansas Blogs, Featured News Home Administrative Actions, Legal Resources, Prescription Drug Pricing, State Rx Legislative Action /by Sarah Lanford and Jennifer ReckToday, the US Supreme Court is scheduled to hear oral arguments in a legal challenge of an Arkansas law that regulates the reimbursement rates that pharmacy benefit managers (PBMs) pay to pharmacies.
How States Can Advance Health Equity while Addressing Health System Costs
/in Health System Costs, Policy Blogs, Featured News Home Accountable Health, Chronic Disease Prevention and Management, Community Benefit, COVID-19, Health Equity, Health System Costs, Hospital/Health System Oversight, Making the Case for Action, Population Health, Quality and Measurement, Social Determinants of Health, Total Cost of Care Benchmark /by Adney RakotoniainaNASHP’s New Hospital Cost Calculator Informs State Cost-Containment Strategies
/in Hospital/Health System Oversight Blogs, Featured News Home Consumer Affordability, Health System Costs, Hospital/Health System Oversight, Making the Case for Action, State Employee Health Plans Hospital/Health System Oversight, State Employee Health Plans /by Marilyn Bartlett, Maureen Hensley-Quinn and Trish RileySurprised that the national average rate that employer-sponsored health plans pay hospitals is 2.5-times higher than Medicare’s reimbursement rate? Or that there is actually no relationship between the volume of publicly covered patients a hospital serves to the prices it charges commercially-insured patients? This price transparency is important as states and employers work to rein […]
States Seek Flexibility in Final Drug Importation Rules to Achieve Consumer Savings
/in Prescription Drug Pricing Colorado, Florida, Maine, New Hampshire, New Mexico, Vermont Blogs, Featured News Home Newly-Enacted Laws, Prescription Drug Pricing, State Rx Legislative Action /by Jennifer Reck, Trish Riley and Johanna ButlerSix states with laws enabling the importation of prescription drugs from Canada – Vermont, Florida, Maine, Colorado, New Mexico, and New Hampshire – are awaiting publication of federal rules currently under review by the Office of Management and Budget. They are eager to see if the final rules address key concerns submitted by the National […]
Why Compare What Employers Pay to What Medicare Pays?
/in Health System Costs Blogs, Featured News Home Consumer Affordability, Health System Costs, Hospital/Health System Oversight, Making the Case for Action, Total Cost of Care Benchmark Hospital/Health System Oversight, State Employee Health Plans /by Adney Rakotoniaina, Marilyn Bartlett and Trish RileyResults from a new RAND Corporation study – Nationwide Evaluation of Health Care Prices Paid By Private Health Plans – show commercial payers reimburse hospitals about 2.5-times more than does Medicare. As expected, hospital officials responded, claiming that public payers underpay for medical services and that it is inappropriate to challenge hospitals now as they battle […]
Medicaid Agencies Implement Innovative Outreach Strategies: Lessons from Kentucky and Virginia
/in COVID-19 State Action Center Kentucky, Virginia Blogs, Featured News Home CHIP, CHIP, COVID-19, Eligibility and Enrollment, Eligibility and Enrollment, Health Coverage and Access, Health Equity, Maternal, Child, and Adolescent Health, Population Health /by Gia GouldAs the pandemic continues and more individuals lose jobs and health insurance, the demand for Medicaid and Children’s Health Insurance Program (CHIP) coverage is rising. Kentucky and Virginia – stripped of their traditional, in-person enrollment strategies – have adapted their outreach efforts to help make enrollment as easy as possible for adults and children to […]
States Can’t Wait – Pennsylvania Leads New Round of State Laws to Tackle Drug Costs
/in Prescription Drug Pricing Blogs, Featured News Home Model Legislation, Prescription Drug Pricing, State Rx Legislative Action /by Trish RileyLast week, Pennsylvania State Sen. Senator Thomas Killion submitted a first-in-the-nation proposal to reduce drug costs in his state using a new international drug pricing model law developed by the National Academy for State Health Policy (NASHP). The International Reference Rates model law “imports” Canadian prices, which can cost 80 percent less than in the […]
State Roles in Preventing and Improving Foster Care Placements for Children with Medical Complexity
/in Policy Featured News Home, Reports Care Coordination, Children/Youth with Special Health Care Needs, Children/Youth with Special Health Care Needs, Chronic and Complex Populations, Integrated Care for Children, Maternal, Child, and Adolescent Health, Physical and Behavioral Health Integration /by Catherine HessStates Explore Pivoting Hospital Community Benefit Requirements to Address Disparities Exposed by COVID-19
/in Health System Costs Blogs, Featured News Home Community Benefit, Consumer Affordability, Health Equity, Health System Costs, Hospital/Health System Oversight, Population Health, Social Determinants of Health /by Anne DeBiasi, Jill Rosenthal and Allie Atkeson